Edward Morrow Atkinson III, EVP, Chief Technical Operations Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 4,378 shares at $489.46 ($2.1M) on 2026-02-17, disclosed to the SEC on 2026-02-19.
Open-market sale of $2.1M VRTX by EVP, Chief Technical Operations Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $483.75 | 1,530 | $740K | 34.9% |
| 2 | $489.46 | 2,031 | $994K | 46.9% |
| 3 | $473.68 | 817 | $387K | 18.2% |
| Total | $484.52 avg | 4,378 | $2.1M | 100% |
| Filing → |
| VRTX | SELL | 2025-11-19 | $1.1M | — | Filing → |
| VRTX | SELL | 2025-02-28 | $1.3M | — | Filing → |
| VRTX | SELL | 2025-02-26 | $1.7M | — | Filing → |